Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
XKR4 antisense RNA 1 (XKR4-AS1) is a putative long noncoding RNA transcribed antisense to the XKR4 gene. No detailed biochemical or molecular characterization is available in the primary literature or widely-used genomic databases as of this writing. Antisense lncRNAs like XKR4-AS1 are often involved in the regulation of the expression level, splicing, or stability of their sense gene counterparts, but direct evidence for such functions specific to XKR4-AS1 is currently lacking in the literature reviewed. There are no known drugs, biomarkers, or therapeutic safety concerns linked to XKR4-AS1. At present, XKR4-AS1 is not considered a druggable or addressable therapeutic target, but rather part of the large class of noncoding RNAs involved in gene regulatory networks[2]. Additional context: There is substantial primary literature on the protein-coding XKR4 gene, which codes for XK-related protein 4, a phospholipid scramblase implicated in apoptotic membrane dynamics[1][3][5]. However, XKR4-AS1 refers specifically to the noncoding, antisense RNA and should not be confused with the protein-coding gene or its product. If you were seeking information about the protein *XK-related protein 4* (XKR4), please specify, as this has therapeutic relevance and is recognized as a scramblase implicated in apoptosis. Given the current data, no authoritative evidence supports XKR4-AS1 as a therapeutic target or disease biomarker.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on XKR4 antisense RNA 1 (XKR4-AS1).